PUBLISHER: TechNavio | PRODUCT CODE: 1911067
PUBLISHER: TechNavio | PRODUCT CODE: 1911067
The global insulin market is forecasted to grow by USD 1346.8 mn during 2025-2030, accelerating at a CAGR of 1.4% during the forecast period. The report on the global insulin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing global prevalence of diabetes, technological advancements in insulin delivery systems, growing demand for biosimilar insulins.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 1.4% |
| CAGR | 1.4% |
| Incremental Value | $1346.8 mn |
Technavio's global insulin market is segmented as below:
By Type
By Distribution Channel
By Application
Geography
This study identifies the growing adoption of smart insulin delivery devices as one of the prime reasons driving the global insulin market growth during the next few years. Also, increasing focus on personalized medicine and digital health and emergence of once-weekly insulin formulations will lead to sizable demand in the market.
The report on the global insulin market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global insulin market vendors that include AdvaCare Pharma, B.Braun SE, Becton Dickinson and Co., Biocon Ltd., Eli Lilly and Co., Embecta Corp., Gan and Lee Pharmaceuticals, Gulf Pharmaceutical Inds., Hi Tech Medics Pvt. Ltd., Hindustan Med Devices Ltd., Nipro Corp., Novo Nordisk AS, Pfizer Inc., Sanofi SA, Tonghua Dongbao Co. Ltd., UltiMed Inc., Wockhardt Ltd.. Also, the global insulin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.